Can a short burst of GLP 1 therapy plus a carefully planned low carb, real food approach help patients keep the weight off and wind back their metabolic disease without staying on injections for life?
In this Quick Case, Endocrinologist Dr Ramy Bishay reviews the evidence for semaglutide in type 2 diabetes and CKD, outlines its relevance and impact on glycaemic, renal and cardiovascular outcomes based on clinical trial evidence, and explains how to navigate PBS access and prescribing requirements (5 mins).
In this Quick Case, GP Dr Rob Hungerford presents a woman with obesity who has achieved significant weight loss on semaglutide but remains above her treatment goals. The case explores the STEP UP trial data and the potential benefits of dose escalation to support further weight loss and personalised obesity management (6 mins).
Professor Rachel Neale explores the complexities of vitamin D deficiency, sun exposure, testing and supplementation, offering practical insights beyond standard guidelines.
Dr Jason Winnett shares how GLP‑1 therapies have transformed his practice and how he integrates them with surgery, dietetics, psychology and exercise physiology in a truly holistic model of obesity care.
Dr Georgia Rigas and Dr Nadia Tejani joins Dr Angela Kwong to unpack perimenopausal weight gain, cardiometabolic risk, and the evolving roles of MHT and GLP‑1s in midlife care.
Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA
Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.
Podcasts
Videos
Clinical Articles
